To describe the epidemiology, clinical features, laboratory manifestations, response to therapy, and factors related to morbidity and mortality in a large group of patients with ehrlichiosis.
Laboratory-based surveillance in the United States.
237 patients whose serum had a fourfold increase or decrease in antibodies to Ehrlichia canis or E. chaffeensis.
Epidemiologic, clinical, laboratory data, hospitalization, duration of illness, complications, and treatment response.
From 1985 through 1990, 237 case-patients were identified in 21 states; rates exceeded 1 per 100 000 per year in only 5 counties.
Incidence rates increased with age and were higher among men.
Mots-clés Pascal : Ehrlichiose, Rickettsialose, Bactériose, Infection, Homme, Etats Unis, Amérique du Nord, Amérique, Prévalence, Epidémiologie
Mots-clés Pascal anglais : Ehrlichia infection, Rickettsialosis, Bacteriosis, Infection, Human, United States, North America, America, Prevalence, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0420464
Code Inist : 002B05B02L8. Création : 199406.